FDA device ID architect leaves as new bodies accredited
This article was originally published in Clinica
Executive Summary
Jay Crowley, who was instrumental in authoring the US FDA's unique device identifier (UDI) rule, is leaving the agency to join private consultancy firm USDM Life Sciences. The news came around the same time the agency accredited global standards organization, GS1, for issuing UDIs to support the implementation of the agency's new regulations.